WELTRUZA
Live / Applied — Non-final action mailed (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 15 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99596389
- Mark type
- Stylized text
- Filed
- 15 Jan 2026
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for the prevention and treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
Prosecution history
- 03 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Mar 2026 — NON-FINAL ACTION E-MAILED
- 03 Mar 2026 — NON-FINAL ACTION WRITTEN
- 24 Feb 2026 — ASSIGNED TO EXAMINER
- 15 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 15 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Jan 2026 — NEW APPLICATION ENTERED